| Year | Sales Value (Million USD) | Year-on-Year Variation (%) |
|---|---|---|
| 2024 | 393.2 | - |
| 2025 | 427.6 | 8.76% |
| 2026 | 461.7 | 7.97% |
| 2027 | 495.7 | 7.37% |
| 2028 | 529.6 | 6.84% |
The compound annual growth rate (CAGR) for the period 2024-2028 is approximately 7.23%, indicating a steady growth in sales of respiratory system medicines in Austria.
Future trends to watch include advancements in respiratory care technologies, the impact of an aging population, and potential regulatory changes that could drive or hinder market growth. Additionally, the integration of digital health solutions and personalized medicine may also play a pivotal role in shaping the market.
